Foundation for innovation
in Cardiometabolism and Nutrition

Targeted delivery of LXR-agonists to atherosclerotic lesions mediated by polydiacetylene micelles

Nanoscale

Targeted delivery of LXR-agonists to atherosclerotic lesions mediated by polydiacetylene micelles

Posted on 

ISO 9001 Certified

OUr Institutionnal Supporters

Our network